In addition to reducing tumor progression via inhibiting HDAC activity, SCFAs may also indirectly reduce tumor progression, since SCFAs have been shown to exert anti-inflammatory properties, and tumor-promoting inflammation is one of the hallmarks of cancer [25,175,176]. The gene discussed is HDAC9; the disease is cancer.